Impact of Race on Outcomes of Advanced Stage Non-Small Cell Lung Cancer Patients Receiving Immunotherapy.
Melisa PasliRadhamani KannaiyanPraveen NamireddyPaul WalkerMahvish MuzaffarPublished in: Current oncology (Toronto, Ont.) (2023)
No difference was observed in OS and PFS in black and white patients. Black patients' reception of timelier immunotherapy was an unanticipated finding. Future studies are necessary to better understand how race impacts patient outcomes.